slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 14,071-14,100
Pages 788
Rows per page 30
Component
14,071-14,100 of 23,622
09
The slide uses a hub-and-spoke diagram to illustrate the three core pillars of the platform.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a process flow diagram to explain the therapeutic mechanism of action.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Solution1 hit
15
Data presented at AACR 2021. Shows two separate mouse model experiments (H1975-OsiR and H1975).Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
16
The slide outlines a two-phase clinical trial structure and the specific patient progression timeline being measured.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
21
The slide outlines a clinical trial methodology for a Phase 1/2 study.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
24
Genprex | Investor Presentation Deck | 39 slidesGenprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
10
The slide uses a process flow diagram to explain the mechanism of action for the REQORSATM immunogene therapy.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
16
The slide outlines a clinical trial methodology comparing combination therapy against monotherapy continuation.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
21
The slide outlines a clinical trial methodology comparing a novel combination therapy against a standard of care control arm.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
24
The slide uses a vertical process flow diagram to illustrate strategic focus areas.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
29
The slide uses a timeline to establish the long-standing nature of the problem and positions the new therapy as a transformative solution.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
05
The diagram uses a bullseye/concentric circle framework to show the hierarchy from disease down to the molecular level.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
11
The slide uses a process diagram to show disease progression and three columns to define the specific conditions.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
14
The slide uses a process-style arrow diagram to represent the sequence of Phase 1 study components.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
16
The slide outlines a 42-day study timeline with a 28-day treatment period.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
19
The diagram uses a brain visualization to represent the integration of AI technologies into the central AI-POWR platform.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
23
The slide outlines a randomized clinical trial structure with a 1:1:1:1 ratio, a 12-month treatment period, and a 1-month follow-up.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
26
The slide outlines a randomized clinical trial structure with three dosing arms and a follow-up period.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
29
Includes specific stopping rules for futility based on Disease Control Rate (DCR).Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
31
Uses a Venn diagram to show the intersection of three core strategic pillars.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
32
Slide 32 of the deck.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
05
The slide uses a layered architecture diagram to show the integration of IBM Consulting, Software, Red Hat, and Infrastructure with external partners and cloud environments.IBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a simple three-pillar process diagram to summarize the company's core business model.IGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank 1 hit
16
The slide uses a vertical diamond-chain diagram to highlight quantitative achievements alongside qualitative differentiators.IGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank 1 hit
17
The diagram uses a concentric ring structure to map business categories to specific partners and their contribution to bookings.IGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank 1 hit
22
IGI | IPO Presentation Deck | 23 slidesIGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank Beat · The Ask1 hit
04
The slide uses a process flow diagram to show the progression of clinical trial cohorts.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
05
The slide uses a process flow diagram to illustrate trial cohorts. Cohorts B and C are greyed out, indicating they are not the focus of this specific update.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
07
The slide uses a process-flow layout to show progression from Phase 1a to 1b to final takeaways.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
15
Immatics | Results Presentation Deck | 25 slidesImmatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit